<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00774033</url>
  </required_header>
  <id_info>
    <org_study_id>P070307</org_study_id>
    <nct_id>NCT00774033</nct_id>
  </id_info>
  <brief_title>Epidermal Cells Delivery and Acute Burns</brief_title>
  <acronym>ENSEM</acronym>
  <official_title>A Randomized Trial Comparing Recell® Autologous Epidermal Cells Harvesting Kits Versus Classic Skin Grafts for the Treatment of Acute Burn in Adults and Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare results obtained with epidermal cell spray and classic
      skin grafting for epidermal replacement in acute burns
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparing the impact in terms of cicatrisation duration and costs between 2 treatments of
      deep 2nd and 3rd degree burns.

      Determine if the costs of the innovating treatment RECELL®, a priori more expensive, are
      counterbalanced by a shorter cicatrisation duration and an improved evolution versus a
      conventional strategy.

      Give an information about efficiency improvement of RECELL® with additional costs
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Not enough patients included
  </why_stopped>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">May 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>80% epithelialisation (recipient + owner sites) at one week. Percent epithelialisation at 1, 2 and 6 weeks.</measure>
    <time_frame>at 1, 2 and 6 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Medical costs at complete epithelialisation</measure>
    <time_frame>At 6, 12 and 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>At 6 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medical assessment of scar quality</measure>
    <time_frame>at 6 weeks and 6, 12, 18 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient self assessment of scar</measure>
    <time_frame>At 6, 12 and 18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Burn</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of acute burn in adults and children by epidermal cell spray</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment of acute burn in adults and children by classic skin grafts</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>autologous epidermal cells harvesting kits</intervention_name>
    <description>autologous epidermal cells harvesting kits used for the treatment of acute burn</description>
    <arm_group_label>1</arm_group_label>
    <other_name>Recell®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>classic skin grafts</intervention_name>
    <description>classic skin grafts used for the treatment of acute burn</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Thermal burns requiring surgical debridement

          -  Area involved &lt; 1260cm²

        Exclusion Criteria:

          -  local or systemic infection

          -  conditions that would interfere with wound healing (diabetes, hypertension,
             inflammatory diseases treated by corticoids)

          -  hypersensitivity to trypsin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier GALL, PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Trousseau</name>
      <address>
        <city>Paris</city>
        <zip>75012</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 15, 2008</study_first_submitted>
  <study_first_submitted_qc>October 15, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 16, 2008</study_first_posted>
  <last_update_submitted>July 25, 2012</last_update_submitted>
  <last_update_submitted_qc>July 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Keratinocytes</keyword>
  <keyword>Cell spray</keyword>
  <keyword>Deep partial thickness burns</keyword>
  <keyword>Full thickness burns</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

